title: The time has arrived for national reimbursement of screening CT colonography.
abstract: OBJECTIVE
  CT colonography (CTC) has been fully validated as an accurate screening test for colorectal carcinoma and is being disseminated globally. There is an abundance of new literature addressing the prior concerns of the U.S. Preventive Services Task Force and the Centers for Medicare & Medicaid Services. Specific areas related to radiation dose, extracolonic findings, and generalizability of CTC to senior patients are discussed.
  
  
  CONCLUSIONS
  The time has arrived for national reimbursement of CTC in the United States.
authors.affiliation: Department of Radiology and Biomedical Imaging, San Francisco VA Medical Center, 4150 Clement St, San Francisco, CA 94121, USA. judy.yee@ucsf.edu
authors.forename: Judy
authors.initials: J
authors.lastname: Yee
authors.forename: Kathryn J
authors.initials: KJ
authors.lastname: Keysor
authors.forename: David H
authors.initials: DH
authors.lastname: Kim
mesh_terms: D023881:Colonography, Computed Tomographic / Q000191:economics*; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging* / Q000453:epidemiology; D055088:Early Detection of Cancer / Q000191:economics; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence*; D008403:Mass Screening / Q000191:economics; D058991:Patient Protection and Affordable Care Act; D014481:United States / Q000453:epidemiology